Intra-and interspecies effects of outer membrane vesicles from Stenotrophomonas maltophilia on β-lactam resistance

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 4, 2016, Pages 2516-2518

  Devos, Simon ^a   Stremersch, Stephan ^a   Raemdonck, Koen ^a   Braeckmans, Kevin ^a   Devreese, Bart ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; PENICILLIN G; ANTIINFECTIVE AGENT; IMIPENEM; TICARCILLIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BURKHOLDERIA CENOCEPACIA; ENZYME ACTIVITY; MEMBRANE VESICLE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTER MEMBRANE; OUTER MEMBRANE VESICLE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; BACTERIUM CONJUGATION; CELL MEMBRANE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; EXOSOME; GENE EXPRESSION; GENETICS; HORIZONTAL GENE TRANSFER; HYDROLYSIS; METABOLISM; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BURKHOLDERIA CENOCEPACIA; CELL MEMBRANE; CONJUGATION, GENETIC; EXTRACELLULAR VESICLES; GENE EXPRESSION; GENE TRANSFER, HORIZONTAL; HYDROLYSIS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; TICARCILLIN;

EID: 84963753750     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02171-15     Document Type: Article

References (10)

1. Abbott IJ, Slavin MA, Turnidge JD, Thursky KA, Worth LJ. 2011. Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. Expert Rev Anti Infect Ther 9:471-488. http://dx.doi.org/10.1586/eri.11.24.
2. Brooke JS. 2012. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 25:2-41. http://dx.doi.org/10.1128/CMR.00019-11.
3. Devos S, Van Oudenhove L, Stremersch S, Van Putte W, De Rycke R, Van Driessche G, Vitse J, Raemdonck K, Devreese B. 2015. The effect of imipenem and diffusible signaling factors on the secretion of outer membrane vesicles and associated Ax21 proteins in Stenotrophomonas maltophilia. Front Microbiol 6:298. http://dx.doi.org/10.3389/fmicb.2015.00298.
4. Braeckmans K, Buyens K, Bouquet W, Vervaet C, Joye P, De Vos F, Plawinski L, Doeuvre L, Angles-Cano E, Sanders NN, Demeester J, De Smedt SC. 2010. Sizing nanomatter in biological fluids by fluorescence single particle tracking. Nano Lett 10:4435-4442. http://dx.doi.org/10.1021/nl103264u.
5. Roding M, Deschout H, Braeckmans K, Rudemo M. 2011. Measuring absolute number concentrations of nanoparticles using single-particle tracking. Phys Rev E Stat Nonlin Soft Matter Phys 84:031920. http://dx.doi.org/10.1103/PhysRevE.84.031920.
6. Hu RM, Chiang KH, Lin CW, Yang TC. 2008. Modified nitrocefin-EDTA method to differentially quantify the induced L1 and L2 β-lactamases in Stenotrophomonas maltophilia. Lett Appl Microbiol 47:457-461. http://dx.doi.org/10.1111/j.1472-765X.2008.02438.x.
7. Van Oudenhove L, De Vriendt K, Van Beeumen J, Mercuri PS, Devreese B. 2012. Differential proteomic analysis of the response of Stenotrophomonas maltophilia to imipenem. Appl Microbiol Biotechnol 95:717-733. http://dx.doi.org/10.1007/s00253-012-4167-0.
8. Aldick T, Bielaszewska M, Uhlin BE, Humpf HU, Wai SN, Karch H. 2009. Vesicular stabilization and activity augmentation of enterohaemorrhagic Escherichia coli haemolysin. Mol Microbiol 71:1496-1508. http://dx.doi.org/10.1111/j.1365-2958.2009.06618.x.
9. Raidt L, Idelevich EA, Dübbers A, Küster P, Drevinek P, Peters G, Kahl BC. 2015. Increased prevalence and resistance of important pathogens recovered from respiratory specimens of cystic fibrosis patients during a decade. Pediatr Infect Dis J 34:700-705. http://dx.doi.org/10.1097/INF.0000000000000714.
10. Hansen CR. 2012. Stenotrophomonas maltophilia: to be or not to be a cystic fibrosis pathogen. Curr Opin Pulm Med 18:628-631. http://dx.doi.org/10.1097/MCP.0b013e328358d4f8.